- Home
- RGNX vs NUS Comparison
RGNX vs NUS Comparison
Compare RGNX & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGNX
- NUS
- Stock Information
- Founded
- RGNX 2008
- NUS 1984
- Country
- RGNX United States
- NUS United States
- Employees
- RGNX N/A
- NUS N/A
- Industry
- RGNX Biotechnology: Biological Products (No Diagnostic Substances)
- NUS Other Pharmaceuticals
- Sector
- RGNX Health Care
- NUS Health Care
- Exchange
- RGNX Nasdaq
- NUS Nasdaq
- Market Cap
- RGNX 661.2M
- NUS 603.4M
- IPO Year
- RGNX 2015
- NUS 1996
- Fundamental
- Price
- RGNX $11.86
- NUS $10.04
- Analyst Decision
- RGNX Strong Buy
- NUS Hold
- Analyst Count
- RGNX 7
- NUS 1
- Target Price
- RGNX $30.29
- NUS $7.00
- AVG Volume (30 Days)
- RGNX 537.9K
- NUS 509.8K
- Earning Date
- RGNX 11-06-2025
- NUS 11-06-2025
- Dividend Yield
- RGNX N/A
- NUS 2.40%
- EPS Growth
- RGNX N/A
- NUS N/A
- EPS
- RGNX N/A
- NUS 2.20
- Revenue
- RGNX $161,318,000.00
- NUS $1,560,391,000.00
- Revenue This Year
- RGNX $198.02
- NUS N/A
- Revenue Next Year
- RGNX $2.67
- NUS $0.98
- P/E Ratio
- RGNX N/A
- NUS $4.55
- Revenue Growth
- RGNX 91.30
- NUS N/A
- 52 Week Low
- RGNX $5.04
- NUS $5.32
- 52 Week High
- RGNX $13.93
- NUS $14.62
- Technical
- Relative Strength Index (RSI)
- RGNX 53.04
- NUS 47.08
- Support Level
- RGNX $10.70
- NUS $9.32
- Resistance Level
- RGNX $12.05
- NUS $9.91
- Average True Range (ATR)
- RGNX 0.73
- NUS 0.55
- MACD
- RGNX -0.10
- NUS 0.00
- Stochastic Oscillator
- RGNX 79.32
- NUS 50.33
About RGNX REGENXBIO Inc.
Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.
About NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc is a health and beauty direct-selling company. It has two primary product categories: beauty products and wellness products. The company develops and distributes nutritional, weight-management products, and food supplements under the Nu Skin and Pharmanex brands, respectively. The company has operations internationally, in more than 50 countries across the Americas, Europe, and the Asia-Pacific.